Bruker 8-K
NegativeEarningsGuidance reaffirmed
U.S. academic weakness and tariffs pressured organic sales; BSI bookings strengthened, with organic growth expected to return in Q2.
Filed 2026-05-06 06:30 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q1 2026 results with FY2026 guidance reaffirmed. Revenue rose 2.7% Y/Y, but fell 4.4% organically as U.S. academic demand, tariffs and currency pressured results; acquisitions and favorable currency translation offset the organic decline. Bruker expects organic revenue growth to return in Q2 and cited stronger BSI bookings.
Key Figures
| Metric | Q1 2026 | Q1 2025 | Y/Y |
|---|---|---|---|
| Revenue | $823M | $801M | 2.7% |
| GAAP operating income | $10.2M | $31.8M | (67.9)% |
| Non-GAAP operating income | $84.2M | $102M | (17.2)% |
| GAAP net income attributable to Bruker Corporation common shareholders | $3.5M | $17.4M | (79.9)% |
| Non-GAAP net income attributable to Bruker Corporation common shareholders | $47M | $70.7M | (33.5)% |
| GAAP diluted EPS | $0.02 | $0.11 | (81.8)% |
| Non-GAAP diluted EPS | $0.31 | $0.47 | (34.0)% |
| Operating cash flow | $71.2M | $65.0M | 9.5% |
| Free cash flow | $47M | $39M | 20.5% |
- Revenue included 2.6% growth from acquisitions and a 4.5% favorable foreign currency impact; BSI revenue grew 2.1% reported but declined 5.0% organically, while BEST revenue grew 12.8% reported and 3.0% organically.
- BSI bookings increased by a high-single-digit percentage organically, and its book-to-bill ratio remained above 1.0 for a third consecutive quarter.
- Cash and cash equivalents were $133M at 3/31/2026, down from $299M at 12/31/2025. Long-term debt was $1.66B; the company repaid $181M of long-term debt during the quarter.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Revenue | FY2026 | $3.57B-$3.60B; 4%-5% reported growth, 1%-2% organic growth | — | Reaffirmed |
| Non-GAAP diluted EPS | FY2026 | $2.10-$2.15; 15%-17% Y/Y growth | — | Reaffirmed |
Revenue guidance includes ≈1.5% growth from M&A and ≈1.5% foreign currency translation tailwind. EPS guidance includes an ≈$0.15, or 8%, currency headwind; constant exchange rate non-GAAP EPS growth is expected to be 23%-25%.
Investor Takeaways
- Watch whether organic revenue growth returns in Q2, as management expects.
- BSI bookings and its book-to-bill ratio will indicate whether the reported booking strength continues.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3